CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Clinical trials for CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) trials appear
Sign up with your email to follow new studies for CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental blood cancer drug trial halted early
Disease control TerminatedThis study tested an experimental drug called NMS-03592088 in 63 adults with acute myeloid leukemia (AML) or chronic myelomonocytic leukemia (CMML) that had come back or not responded to standard treatments. The goal was to find a safe dose and see if the drug could shrink or con…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Phase: PHASE1, PHASE2 • Sponsor: Nerviano Medical Sciences • Aim: Disease control
Last updated May 26, 2026 10:30 UTC
-
Experimental blood cancer drug trial halted early
Disease control TerminatedThis study tested a new drug called S227928, alone or with another drug (venetoclax), in people with certain blood cancers (AML, MDS/AML, or CMML) that returned or didn't respond to prior treatment. The goal was to find a safe dose and see if it could help control the cancer. The…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Phase: PHASE1, PHASE2 • Sponsor: Servier Bio-Innovation LLC • Aim: Disease control
Last updated May 26, 2026 10:25 UTC